Literature DB >> 8100566

Insect-transmitted vertebrate viruses: flaviviridae.

G V Ludwig1, L C Iacono-Connors.   

Abstract

The Flaviviridae include almost 70 viruses, nearly half of which have been associated with human disease. These viruses are among the most important arthropod-borne viruses worldwide and include dengue, yellow fever, and Japanese encephalitis viruses. Morbidity and mortality caused by these viruses vary, but collectively they account for millions of encephalitis, hemorrhagic fever, arthralgia, rash, and fever cases per year. Most of the members of this family are transmitted between vertebrate hosts by arthropod vectors, most commonly mosquitoes or ticks. Transmission cycles can be simple or complex depending on the hosts, vectors, the virus, and the environmental factors affecting both hosts and viruses. Replication of virus in invertebrate hosts does not seem to result in any significant pathology, which suggests a close evolutionary relationship between virus and vector. Another example of this relationship is the ability of these viruses to grow in invertebrate cell culture, where replication usually results in a steady state, persistent infection, often without cytopathic effect. Yields of virus from insect cell culture vary but are generally similar to yields in vertebrate cells. Replication kinetics are comparable between insect and vertebrate cell lines, despite differences in incubation temperature. Both vertebrate and insect cell culture systems continue to play a significant role in flavivirus isolation and the diagnosis of disease caused by these agents. Additionally, these culture systems permit the study of flavivirus attachment, penetration, replication, and release from cells and have been instrumental in the production and characterization of live-attenuated vaccines. Both vertebrate and insect cell culture systems will continue to play a significant role in basic and applied flavivirus research in the future.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8100566      PMCID: PMC7089231          DOI: 10.1007/bf02633958

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  98 in total

1.  Expression of the structural proteins of dengue 2 virus and yellow fever virus by recombinant vaccinia viruses.

Authors:  Y S Hahn; E M Lenches; R Galler; C M Rice; J Dalrymple; J H Strauss
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

2.  Transcription of infectious yellow fever RNA from full-length cDNA templates produced by in vitro ligation.

Authors:  C M Rice; A Grakoui; R Galler; T J Chambers
Journal:  New Biol       Date:  1989-12

3.  Cell-associated West Nile flavivirus is covered with E+pre-M protein heterodimers which are destroyed and reorganized by proteolytic cleavage during virus release.

Authors:  G Wengler; G Wengler
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

4.  Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: construction of single and multiple mutants in a full-length cDNA clone.

Authors:  N L Davis; N Powell; G F Greenwald; L V Willis; B J Johnson; J F Smith; R E Johnston
Journal:  Virology       Date:  1991-07       Impact factor: 3.616

5.  Humoral immune response to the entire human immunodeficiency virus envelope glycoprotein made in insect cells.

Authors:  J R Rusche; D L Lynn; M Robert-Guroff; A J Langlois; H K Lyerly; H Carson; K Krohn; A Ranki; R C Gallo; D P Bolognesi
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

6.  Selection for accelerated penetration in cell culture coselects for attenuated mutants of Venezuelan equine encephalitis virus.

Authors:  R E Johnston; J F Smith
Journal:  Virology       Date:  1988-02       Impact factor: 3.616

Review 7.  Review article initial stages in infection with animal viruses.

Authors:  N J Dimmock
Journal:  J Gen Virol       Date:  1982-03       Impact factor: 3.891

8.  Preparation of an attenuated dengue 4 (341750 Carib) virus vaccine. II. Safety and immunogenicity in humans.

Authors:  C H Hoke; F J Malinoski; K H Eckels; R M Scott; D R Dubois; P L Summers; T Simms; J Burrous; S E Hasty; W H Bancroft
Journal:  Am J Trop Med Hyg       Date:  1990-08       Impact factor: 2.345

9.  Protection of mice against yellow fever virus encephalitis by immunization with a vaccinia virus recombinant encoding the yellow fever virus non-structural proteins, NS1, NS2a and NS2b.

Authors:  J R Putnak; J J Schlesinger
Journal:  J Gen Virol       Date:  1990-08       Impact factor: 3.891

10.  Isolation of a Singh's Aedes albopictus cell clone sensitive to Dengue and Chikungunya viruses.

Authors:  A Igarashi
Journal:  J Gen Virol       Date:  1978-09       Impact factor: 3.891

View more
  4 in total

1.  First Isolation of a Novel Aquatic Flavivirus from Chinook Salmon (Oncorhynchus tshawytscha) and Its In Vivo Replication in a Piscine Animal Model.

Authors:  Esteban Soto; Alvin Camus; Susan Yun; Tomofumi Kurobe; John H Leary; Thomas G Rosser; Jennifer A Dill-Okubo; Akinyi Carol Nyaoke; Mark Adkison; Allan Renger; Terry Fei Fan Ng
Journal:  J Virol       Date:  2020-07-16       Impact factor: 5.103

2.  A New Clade of Insect-Specific Flaviviruses from Australian Anopheles Mosquitoes Displays Species-Specific Host Restriction.

Authors:  Agathe M G Colmant; Jody Hobson-Peters; Helle Bielefeldt-Ohmann; Andrew F van den Hurk; Sonja Hall-Mendelin; Weng Kong Chow; Cheryl A Johansen; Jelke Fros; Peter Simmonds; Daniel Watterson; Chris Cazier; Kayvan Etebari; Sassan Asgari; Benjamin L Schulz; Nigel Beebe; Laura J Vet; Thisun B H Piyasena; Hong-Duyen Nguyen; Ross T Barnard; Roy A Hall
Journal:  mSphere       Date:  2017-07-12       Impact factor: 4.389

Review 3.  Ocular Manifestations of Emerging Flaviviruses and the Blood-Retinal Barrier.

Authors:  Sneha Singh; Ashok Kumar
Journal:  Viruses       Date:  2018-09-28       Impact factor: 5.048

4.  NS4/5 mutations enhance flavivirus Bamaga virus infectivity and pathogenicity in vitro and in vivo.

Authors:  Agathe M G Colmant; Helle Bielefeldt-Ohmann; Laura J Vet; Caitlin A O'Brien; Richard A Bowen; Airn E Hartwig; Steven Davis; Thisun B H Piyasena; Gervais Habarugira; Jessica J Harrison; Jody Hobson-Peters; Roy A Hall
Journal:  PLoS Negl Trop Dis       Date:  2020-03-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.